Today, there is a solid clinical standard for treating joint disease: the total joint replacement. Yet, while the surgical devices and techniques used to implant them have been largely perfected, today’s standard replacement joints don’t last forever. The limited lifespan of common replacement joints limits their use to patients aged 55 or older. This leaves patients between ages 18 and 55 suffering from cartilage damage, traumatic injury, or early stage cartilage loss with limited treatment options. 

Our company, Nanochon, is developing an implant that is designed to not only replace lost and damaged cartilage, but also to encourage new tissue growth. Using 3-D printing and a novel material, the Nanochon implant is a sturdy medical advancement that is both an orthopedic load bearing implant as well a tissue growth scaffold. The Nanochon implant has the potential to deliver  faster and more successful recoveries for patients,while reducing costs to health providers, payers, and patients. Nanochon’s aim is to set a new clinical standard for cartilage restoration. 


Specializing in patient specific solutions for treating pediatric and young adult joint injury.

Providing faster and better recovery and a life-long solution for joint repair in children and young adults.

Employing cutting edge nanomaterials and 3-D printing to create implants specific to a patient’s joint that repair and regrow healthy bone and cartilage.